Streetbeat News

Stock Prices

ACN

Accenture (NYSE:ACN) has seen a significant bearish sentiment from big-money investors, as evidenced by recent options trading activity. Benzinga's options scanner revealed 9 trades, predominantly puts, indicating a bearish outlook. The trades target a price range of $300 to $370 for ACN over the next 3 months. This unusual activity suggests insiders may anticipate a price movement. ACN's current market position shows a slight decline in stock price with potential oversold conditions, and an earnings announcement is expected in 52 days.

Portfolio Pulse from Benzinga Insights

April 29, 2024 | 6:01 pm

PFG

In the last three months, 10 analysts have assessed Principal Financial Group (NASDAQ:PFG), with the majority remaining indifferent. The average 12-month price target for PFG has been raised to $84.1, reflecting a positive shift of 2.42% from the previous target. Despite this optimism, PFG faces financial challenges, including a -14.6% decline in revenue growth and a net margin of -32.4%, indicating profitability issues. The company's debt-to-equity ratio is below industry norms, suggesting a sound financial structure.

Portfolio Pulse from Benzinga Insights

April 29, 2024 | 6:00 pm

ASML

ASML Holding (NASDAQ:ASML) has significantly outperformed the market with an average annual return of 26.16% over the past 15 years, turning a $100 investment into $3,170.80 today. The company's market capitalization stands at $359.43 billion.

Portfolio Pulse from Benzinga Insights

April 29, 2024 | 6:00 pm

KNSL

Kinsale Cap Gr (NYSE:KNSL) has significantly outperformed the market with an average annual return of 34.61% over the past 5 years, growing a $100 investment to $487.93. The company now has a market capitalization of $8.42 billion.

Portfolio Pulse from Benzinga Insights

April 29, 2024 | 6:00 pm

DASH

Over the past three months, 27 analysts have provided varied opinions on DoorDash (NASDAQ:DASH), with recent ratings showing a shift towards more bullish views. The average 12-month price target for DASH has been raised to $141.41, indicating an 18.96% increase from the previous target. Analysts from firms like Oppenheimer, Loop Capital, and Deutsche Bank have adjusted their price targets and ratings, reflecting optimism about DoorDash's market position and financial performance. Despite challenges in profitability and asset utilization, DoorDash's market capitalization and revenue growth outperform industry averages.

Portfolio Pulse from Benzinga Insights

April 29, 2024 | 6:00 pm

CARR

Carrier Global's stock price increased following TD Cowen's decision to maintain a Buy rating and raise its price target from $66 to $70.

Portfolio Pulse from Benzinga Newsdesk

April 29, 2024 | 5:59 pm

BTCUSD

ETHUSD

Cryptocurrency analyst Benjamin Cowen predicts further bearish momentum for Ethereum (ETH) against Bitcoin (BTC), suggesting the ETH/BTC ratio's bottom is still months away, likely pending a Federal Reserve policy pivot. Despite a recent market pump, Cowen draws parallels to 2019's pre-rate cut scenario, indicating a potential short-lived rally. Ethereum has seen a 6.66% increase against Bitcoin in the past week but is down over longer periods. The analysis underscores the impact of macroeconomic factors on cryptocurrencies.

Portfolio Pulse from Khyathi Dalal

April 29, 2024 | 5:58 pm

DPZ

Domino's Pizza Inc (NYSE:DPZ) reported a strong start to FY24 with a 6% year-on-year sales growth to $1.085 billion, surpassing analyst expectations. EPS of $3.58 also beat estimates, attributed to better supply chain margin, lower interest expense, and lower income tax, despite investment losses in DPC Dash (Domino's China). U.S. same-store sales grew by 5.6%, with order count growth across all income cohorts. DPZ ended the quarter with 20,755 global locations, a 3.7% increase. Shares rose 4.39% to $521.00.

Portfolio Pulse from Shivani Kumaresan

April 29, 2024 | 5:57 pm

ANVS

Annovis Bio Inc (NASDAQ:ANVS) shares plummeted after releasing Phase 2/3 study data for buntanetap in Alzheimer's patients, showing no statistically significant difference in ADCS-CGIC scores and a large placebo effect in ADCS-ADL scores. However, improvements were observed in ADAS-Cog 11 scores, indicating a potential symptomatic effect with a disease-modification trend. The company plans to discuss the data with the FDA and proceed to a next Phase 3 study.

Portfolio Pulse from Vandana Singh

April 29, 2024 | 5:53 pm

SMCI

Super Micro Computer shares are trading higher ahead of its Q3 earnings report tomorrow.

Portfolio Pulse from Benzinga Newsdesk

April 29, 2024 | 5:49 pm